- $56.13bn
- $75.31bn
- $28.43bn
Annual balance sheet for Medline, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | |
| Standards: | — | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | — | 1,556 | 199 | 1,939 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | 2,960 | 3,219 | 3,533 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | — | 8,809 | 8,272 | 10,679 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 4,797 | 4,979 | 5,210 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | — | 36,122 | 35,978 | 38,484 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 2,131 | 2,440 | 2,490 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | — | 19,145 | 19,454 | 27,747 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | — | 16,977 | 16,524 | 10,737 |
| Total Liabilities & Shareholders' Equity | — | 36,122 | 35,978 | 38,484 |
| Total Common Shares Outstanding |